Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Imprinted CDKN1C Is a Tumor Suppressor in Rhabdoid Tumor and Activated by Restoration of SMARCB1 and Histone Deacetylase Inhibitors

14 Feb 2009

Abstract excerpt

SMARCB1 is deleted in rhabdoid tumor, an aggressive paediatric malignancy affecting the kidney and CNS. We hypothesized that the oncogenic pathway in rhabdoid tumors involved epigenetic silencing of key cell cycle regulators as a consequence of altered chromatin-remodelling, attributable to loss of SMARCB1, and that this hypothesis if proven could provide a biological rationale for testing epigenetic therapies in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to Cancer-related gene regulation
Share to Chromatin Remodeling and Cancer

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 19221586
DOI: 10.1371/journal.pone.0004482

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Imprinted CDKN1C Is a Tumor Suppressor in Rhabdoid Tumor and Activated by Restoration of SMARCB1 and Histone Deacetylase InhibitorsPMID 19221586Read ↗

Emerging therapeutic targets for the treatment of malignant rhabdoid tumors.Semantic proximity Read ↗

SMARCB1 loss induces druggable cyclin D1 deficiency via upregulation of MIR17HG in atypical teratoid rhabdoid tumorsSemantic proximity Read ↗

Biology and Treatment of Rhabdoid TumorSemantic proximity Read ↗

Rhabdoid tumors: an initial clue to the role of chromatin remodeling in cancer.Semantic proximity Read ↗

Development and epigenetic regulation of Atypical teratoid/rhabdoid tumors in the context of cell-of-origin and halted cell differentiationSemantic proximity Read ↗

Atypical teratoid/rhabdoid tumors—current concepts, advances in biology, and potential future therapiesSemantic proximity Read ↗

Translational genomics of malignant rhabdoid tumours: Current impact and future possibilities.Semantic proximity Read ↗

The CoREST complex inhibitor, corin, leads to decreased tumor growth, increased cellular differentiation and extended lifespan in atypical teratoid rhabdoid tumor xenograft modelsSemantic proximity Read ↗

SMARCB1 loss interacts with neuronal differentiation state to block maturation and impact cell stabilitySemantic proximity Read ↗

Direct therapeutic targeting of SWI/SNF induces epigenetic reprogramming and durable tumor regression in rhabdoid tumorSemantic proximity Read ↗

Inhibition of MYC attenuates tumor cell self‐renewal and promotes senescence in SMARCB1‐deficient Group 2 atypical teratoid rhabdoid tumors to suppress tumor growth in vivoSemantic proximity Read ↗

Loss of CDKN1C in a Recurrent Atypical Teratoid/Rhabdoid Tumor.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.